Navigation Links
Halozyme Therapeutics Presents Pre-Clinical Studies of Systemic Delivery of Pegylated rHuPH20 Enyzme in Prostate Cancer Models at American Association for Cancer Research Conference
Date:4/15/2008

- New Approach to Targeting the Tumor Microenvironment -

SAN DIEGO, April 15 /PRNewswire-FirstCall/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced new pre-clinical findings on the treatment of prostate cancer models at the American Association for Cancer Research (AACR) conference. Halozyme is investigating its Pegylated-rHuPH20 enzyme (PEGrHuPH20) as a candidate for the systemic treatment of tumors rich in hyaluronan (HA) in combination with chemotherapy.

The studies explored the physiologic responses to enzymatic removal of HA-based matrices surrounding tumor cells in the tumor microenvironment of prostate tumors following systemic administration of its PEGrHuPH20 pre-clinical candidate. In animal pharmacokinetic models, PEGrHuPH20 demonstrated a more than 2,000-fold increase in plasma half-life compared to the unmodified enzyme. Prostate tumors were grown around the bone as a model of elevated interstitial fluid pressure (IFP). Treatment commenced when tumors had reached approximately 500 mm3 in size and pressure within the tumor had reached 30-40 mm Hg.

The objectives of these studies were to determine whether HA-dependent pericellular matrices produced in vitro and in vivo by hormone refractory prostate cancer cell line could be enzymatically depleted in prostate carcinoma xenografts following intravenous (IV) administration of the PEGrHuPH20 enzyme. The dose dependent effects of systemic enzyme treatment were evaluated by a combination of direct micropressure measurements, magnetic resonance imaging (MRI), ultrasound, immunohistochemistry, and determination of tumor water content. A summa
'/>"/>

SOURCE Halozyme Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Halozyme Therapeutics Announces Peer-Reviewed Publications of the INFUSE-LR Clinical Trial Results and Clinical Practice Experience With Hylenex
2. Halozyme Therapeutics Completes Enrollment in Chemophase Phase I/IIa Clinical Trial for Superficial Bladder Cancer
3. Nektar Therapeutics to Present Positive Data at Upcoming Medical and Scientific Meetings
4. Echo Therapeutics Announces Positive Results with the Prelude(TM) SkinPrep System, the Next-Generation Skin Permeation Medium for its Symphony(TM) Transdermal Continuous Glucose Monitoring System
5. Recent siRNA Research Publications Support Silence Therapeutics Combined Development Approach
6. European Regulatory Agency Accepts Cell Therapeutics, Inc.s Marketing Authorization Application for XYOTAX(TM) for Lung Cancer for Review
7. CV Therapeutics Anti-Ischemic Therapy Ranexa(R) Significantly Reduces Cardiac Chest Pain Symptoms and Recurrent Ischemia in MERLIN-TIMI 36 Patients With Angina
8. Michael J. Fox Foundation Commits up to $10 Million for Pre-Clinical Drug Development Under Therapeutics Development Initiative
9. Synvista Therapeutics Presents New Preclinical Data Demonstrating the Value of Haptoglobin Genotype Testing In Diabetes at ACC Scientific Sessions
10. Cell Therapeutics, Inc. (CTI) Announces Enrollment Complete in Phase III EXTEND (PIX301) Clinical Trial of Pixantrone in Patients With Second or Greater Relapse of Diffuse Large B Cell NHL
11. Dynamis Therapeutics, Inc. Discovers RAGE Inhibitor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... July 30, 2014 PuraMed BioScience ® ... of over-the-counter (OTC) medicinal and healthcare products, announced ... M name along with the name,s red and ... the trademarked name MigraPure ®  going forward. ... PuraMed,s homeopathic, natural migraine pain reliever will be ...
(Date:7/30/2014)... 30, 2014  Today the US Surgeon General issued the ... tanning or sun burns stating they can lead directly to ... Boris Lushniak , says that "skin cancer is a major ... much exposure to indoor and outdoor ultraviolet light is a ... Medicine, in Boca Raton, Florida , ...
(Date:7/30/2014)... July 30, 2014  El Camino Hospital, a leader ... is utilizing the Leaf Patient Monitoring system to help ... movement of patients susceptible to bed sores. ... 138-patient study of the system, which showed dramatic improvement ... patients regularly is the one of the most effect ...
Breaking Medicine Technology:PuraMed BioScience Rebrands its Natural Migraine Relief Medication, LipiGesic M 2PuraMed BioScience Rebrands its Natural Migraine Relief Medication, LipiGesic M 3Indoor and Outdoor Sun Tanning or Sun Burns Directly Linked to Deadly Melanoma Skin Cancer 2El Camino Hospital Utilizes Cutting-Edge Leaf Patient Monitor System to Help Reduce Risk of Pressure Ulcers 2El Camino Hospital Utilizes Cutting-Edge Leaf Patient Monitor System to Help Reduce Risk of Pressure Ulcers 3
... Conn., March 30, 2011 Attendees of the 60th ... New Orleans, La., can see first hand the benefits ... Available for sale in the U.S., Synapse 3D is ... directly into Synapse® Cardiovascular, Fujifilm,s CVIS / C-PACS. During ...
... PORT WASHINGTON, N.Y., March 30, 2011 Premier Heart, LLC ... 11, the 60th Annual Scientific Sessions and Expo of the ... in New Orleans. The MCG offers completely non-invasive cardiac testing ... diagnosis" according to its latest US FDA 510K Clearance.  MCG ...
Cached Medicine Technology:Fujifilm Highlights Synapse® 3D at ACC 2Fujifilm Highlights Synapse® 3D at ACC 3Premier Heart to Exhibit its Multifunction CardioGram (MCG™) at American College of Cardiology in New Orleans April 2-5 2
(Date:7/30/2014)... can happen in an instant: A small child pulls up ... critically injured when the furniture tips over. "Every parent ... homes and imagine what could tip over, fall off walls ... becoming a reality," Dr. Alex Rosenau, president of the American ... Between 2009 and 2011, roughly 43,000 people ended up ...
(Date:7/30/2014)... New York (PRWEB) July 30, 2014 ... uncontrollable brain bleeding has filed a Xarelto lawsuit ( ... the blood thinner, Bernstein Liebhard LLP reports. According to ... for the District of Vermont on July 25th, the ... when he suffered an irreversible brain bleed that ultimately ...
(Date:7/30/2014)... July 30, 2014 (HealthDay News) -- Some obese people ... the reward centers in their brains when they see ... how this mutation triggers feelings of pleasure and gratification ... help improve strategies designed to prevent overeating, the scientists ... obese. Obesity is typically caused by a combination ...
(Date:7/30/2014)... ... ... ... , UCLA researchers interviewed people with diverticulitis and confirmed that many suffer psychological and physical symptoms long after their acute illness ... led by Dr. Brennan Spiegel interviewed patients in great detail about the symptoms they experience weeks, months or even years after an ...
(Date:7/30/2014)... 2014 LTC Consumer, an independent, free online ... insurance, features an Instant Quote tool on its website, ... LTC Consumer. Quotes are free and unlimited. , The ... seven areas – including age, gender, and state of residence ... (you don’t need to enter any contact information to get ...
Breaking Medicine News(10 mins):Health News:Tip-Over Furniture Can Kill Kids 2Health News:Xarelto Lawsuit Alleges Man’s Death from Uncontrollable Brain Bleeding Was Caused by Xarelto, Bernstein Liebhard LLP Reports 2Health News:Xarelto Lawsuit Alleges Man’s Death from Uncontrollable Brain Bleeding Was Caused by Xarelto, Bernstein Liebhard LLP Reports 3Health News:Gene Mutation May Make Food More Tempting 2Health News:Diverticulitis patients reveal psychological, physical symptoms long after acute attacks 2Health News:Diverticulitis patients reveal psychological, physical symptoms long after acute attacks 3Health News:LTC Consumer Launches Online Tool for Getting Instant Long Term Care Insurance Estimates 2
... By Kathleen Doheny HealthDay Reporter , TUESDAY, ... two strains of human papillomavirus (HPV) that are most likely ... with the Pap test, may be more accurate for many ... And, for those women who are HPV-positive, using the ...
... surrounding the Food and Drug Administration,s ruling that Avastin ... cancer, a new multinational Phase III clinical trial shows ... cancer patients when given before surgery. At ... Oncology, the nation,s premier association of clinical oncologists, Harry ...
... treated at a U.S. military hospital in Afghanistan often ... the September issue of Infection Control and Hospital ... Epidemiology of America. The findings underscore the need for ... soldiers and local patients are treated, the study,s authors ...
... Toronto,s psychology department show that people who use ... surgery are viewed more negatively than those who use ... younger adults are more negative about using anti-aging methods ... the rapid growth of the anti-aging cosmetic industry, age ...
... HealthDay Reporter , TUESDAY, Aug. 23 ... (ADHD) have a much higher risk of developing a ... ADHD experts, the current observation does not come as ... children with ADHD stand a much higher chance of ...
... responsible for cells of different tissues of our body to ... matching receptors on the surface of their target cells and ... single genetic alteration can be sufficient for the whole system ... for such a growth factor or for the matching receptor ...
Cached Medicine News:Health News:HPV Test Might Be Better Predictor of Cervical Cancer Than Pap Smear 2Health News:HPV Test Might Be Better Predictor of Cervical Cancer Than Pap Smear 3Health News:Clinical trial shows benefit to adding avastin to neoadjuvant chemotherapy in breast cancer patients 2Health News:Study: Afghan patients a common source of drug-resistant bacteria 2Health News:U of T research shows anti-aging techniques not yet viewed as acceptable 2Health News:Study Links Writing Difficulties to ADHD 2Health News:Study Links Writing Difficulties to ADHD 3Health News:Stop signal for leukemia stem cells 2
... Acclaim 7000 Nd:YAG laser allows you ... cosmetic procedures such as hair removal, ... our Dermique LaserFACIAL for sun-damaged skin. ... parameters for customizing treatment based on ...
... full system for hair removal, with scanner and ... hair reduction system. The 90W laser generates ... hair bulb and bugle. To ease and optimise ... tissue through the MedArt® 413 scanner.,The laser beam ...
Reusable Components Compatible with VERSASTEP™ Reposable Access System....
These are the Reusable Components (minus cannula), to be used with the VersaStep™ Plus Reposable Short System....
Medicine Products: